Cardiovascular Benefits of Early SGLT2i Use for Diabetes With Acute Myocardial Infarction: A Nationwide Cohort Study

Published: 25 April 2025| Version 3 | DOI: 10.17632/6h29fz6fnf.3
Contributor:
Sheng-Fan Wang

Description

Supplementary: Cardiovascular Benefits of SGLT2 Inhibitor in Diabetic Patients during Early-Phase Acute Myocardial Infarction Care

Files

Institutions

  • Taipei Veterans General Hospital

Categories

Data Analysis

Licence